It has been reported that due to the inhibition of PLK1 and mitochondrial dysfunction, the apoptosis rate of HCC cells increases, and a synergistic anti‐tumor effect can be observed both in vitro and in vivo [20]. Here, PLK1 is linked to hepatocellular carcinoma.